Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member., Inc. (AMZN) Will Win in the Long Term Against All Odds

Page 1 of 2, Inc. (NASDAQ:AMZN) is the world’s largest online retailer. The company’s stock performance has been cyclical in the recent past. It is also facing stiff competition from other e-commerce players as it scales up its presence and infrastructure through a lot of investments, even at the expense of profits. There is still a lot of value in the stock, however, which makes it a winner in the long term., Inc. (NASDAQ:AMZN)

First quarter results

Amazon’s primary source of revenue is the sale of a diverse range of products and services to customers. It had annual sales of $60 billion in 2012 and has been registering impressive growth over the years. According to the company’s latest financial results, revenue rose 22% to $16 billion, but growth slowed from last year. The reason behind this phenomenon was attributed to the investment of the company to create new infrastructure and newer avenues for growth. This can be validated by looking at Amazon’s heavy investment in cloud computing technologies and digital content.

One of the main positives of the company is its huge cash pile, which currently stands at $7.9 billion. This will allow Amazon to make investments and acquisitions whenever required and also earn good returns. One recent acquisition is Goodreads.

The Amazon-Goodreads deal

Recently,, Inc. (NASDAQ:AMZN) acquired Goodreads, a social network for books. Goodreads is a popular book networking site with more than 16 million members who have written over 23 million reviews. People review and rate books and can also follow others with similar interests. The company was started in 2007 and has created a niche for itself as a one-stop source of recommendations for all books. The terms of Amazon-Goodreads deal have not yet been disclosed, though the deal is expected to close in the next quarter and may cost Amazon as much as $200 million.

This move by, Inc. (NASDAQ:AMZN) came injust weeks after another book recommender site, Bookish, was launched with the intent to create stronger link between authors, publishers and readers. Amazon, with its deep pockets, regularly makes such acquisitions as a means of growth. But this deal is significant because Amazon already owned some or all of Goodread’s competitors, like Shelfari and LibraryThing. Market reactions to the deal were not very jubilant and some of the readers expressed their concerns that Amazon might influence their book purchases by getting to know about reading habits from Goodreads.

What Amazon is getting from the deal?

It seems that the deal has been beneficial to both sides, but the advantages are slightly more tilted towards Amazon. For Amazon, the deal definitely provides a social angle to its website. While Amazon also has an extensive list of book reviews by its members, it did not have the social layer that will now be provided by Goodreads. Moreover, the deal will bring in additional customers and readers to Amazon’s website who were only following Goodreads up until now. It will further consolidate, Inc. (NASDAQ:AMZN)’s power to determine which authors get exposure for their work. However, it is interesting to note that Amazon’s own book reviews faced issues due to their quality and sometimes questionable authorship. After acquiring Goodreads, this problem may be sorted out as Goodreads is a more trustworthy brand. From the point of view of Goodreads, it was looking for a new platform and the support it needs to continue to grow and innovate.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!